Cryo-Cell International, Inc. was notified by Duke University of the termination of their Patent and Technology License Agreement on May 17, 2025, following claims of breach by both parties. This termination impacts their exclusive rights in certain products related to disease management and follows an ongoing arbitration regarding the agreement.